Daiwa Securities Group Inc. - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$2,0000.0%5330.0%0.00%
Q1 2020$2,000
-33.3%
5330.0%0.00%
Q4 2019$3,0000.0%5330.0%0.00%
Q3 2019$3,0000.0%5330.0%0.00%
Q2 2019$3,000
+50.0%
533
+37.4%
0.00%
Q1 2019$2,0000.0%3880.0%0.00%
Q4 2018$2,0000.0%3880.0%0.00%
Q3 2018$2,000
-33.3%
3880.0%0.00%
Q2 2018$3,0000.0%3880.0%0.00%
Q1 2018$3,0003880.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q1 2018
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders